Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    January 2017
  1. VAN DER REE MH, de Vree JM, Stelma F, Willemse S, et al
    Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.
    Lancet. 2017 Jan 10. pii: S0140-6736(16)31715.
    PubMed     Text format     Abstract available


  2. ZEISEL MB, Baumert TF
    Clinical development of hepatitis C virus host-targeting agents.
    Lancet. 2017 Jan 10. pii: S0140-6736(17)30043.
    PubMed     Text format    


    December 2016
  3. LIVINEC B
    Estimating the burden of hepatitis.
    Lancet. 2016;388:2738-2739.
    PubMed     Text format    


    November 2016
  4. GHINEA N, Lipworth W, Day R, Hill A, et al
    Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries.
    Lancet. 2016 Nov 3. pii: S0140-6736(16)32051.
    PubMed     Text format    


    October 2016
  5. GAO YQ, Zhang X, Li M, Zhou ZH, et al
    Bushenjianpi formula combined with entecavir for HBeAg-negative chronic hepatitis B patients: a multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2016;388 Suppl 1:S33.
    PubMed     Text format     Abstract available


    September 2016
  6. MOHAMMADI D
    Lasker Foundation announces award winners for 2016.
    Lancet. 2016;388:1144-5.
    PubMed     Text format    


  7. PIROTH L, Rabaud C, Rey D, Schmit JL, et al
    Hepatitis C: the path towards effective universal therapy.
    Lancet. 2016;388:1051-2.
    PubMed     Text format    


    July 2016

  8. Towards elimination of viral hepatitis by 2030.
    Lancet. 2016;388:308.
    PubMed     Text format    


  9. KAMARULZAMAN A, Reid SE, Schwitters A, Wiessing L, et al
    Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30769.
    PubMed     Text format     Abstract available


  10. ALTICE FL, Azbel L, Stone J, Brooks-Pollock E, et al
    The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30856.
    PubMed     Text format     Abstract available


  11. DOLAN K, Wirtz AL, Moazen B, Ndeffo-Mbah M, et al
    Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30466.
    PubMed     Text format     Abstract available


  12. RICH JD, Beckwith CG, Macmadu A, Marshall BD, et al
    Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30379.
    PubMed     Text format     Abstract available


  13. RUBENSTEIN LS, Amon JJ, McLemore M, Eba P, et al
    HIV, prisoners, and human rights.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30663.
    PubMed     Text format     Abstract available


  14. RATHI S
    Rules and rues.
    Lancet. 2016;388:122-3.
    PubMed     Text format    


  15. STANAWAY JD, Flaxman AD, Naghavi M, Fitzmaurice C, et al
    The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.
    Lancet. 2016 Jul 6. pii: S0140-6736(16)30579.
    PubMed     Text format     Abstract available


  16. WIKTOR SZ, Hutin YJ
    The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts.
    Lancet. 2016 Jul 6. pii: S0140-6736(16)31018.
    PubMed     Text format    


    May 2016
  17. 'T HOEN EF
    Indian hepatitis C drug patent decision shakes public health community.
    Lancet. 2016 May 26. pii: S0140-6736(16)30656.
    PubMed     Text format    



  18. Hepatitis C: global ambition, national realities.
    Lancet. 2016;387:1970.
    PubMed     Text format    


  19. KELLY D
    Hepatitis C viraemia after apparent spontaneous clearance.
    Lancet. 2016;387:1968.
    PubMed     Text format    


  20. INDOLFI G, Mangone G, Bartolini E, Moriondo M, et al
    Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child.
    Lancet. 2016;387:1967-8.
    PubMed     Text format    


    April 2016
  21. LOCARNINI S, Chen DS, Shibuya K
    No more excuses: viral hepatitis can be eliminated.
    Lancet. 2016;387:1703-4.
    PubMed     Text format    


    March 2016
  22. CSETE J, Kamarulzaman A, Kazatchkine M, Altice F, et al
    Public health and international drug policy.
    Lancet. 2016 Mar 23. pii: S0140-6736(16)00619.
    PubMed     Text format    


  23. CORRIGAN M, Alrubaiy L, China L
    Hepatology training in the UK.
    Lancet. 2016;387:1055.
    PubMed     Text format    


    January 2016
  24. MCCALL C
    Australia commits funds to curb hepatitis C epidemic.
    Lancet. 2016;387:419.
    PubMed     Text format    


    November 2015
  25. WILLIAMS R, Ashton K, Aspinall R, Bellis MA, et al
    Implementation of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2015;386:2098-111.
    PubMed     Text format    



  26. Hepatitis C: cost of lost opportunities.
    Lancet. 2015;386:1917.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: